Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology

When word got out on August 26, 2024, that McKesson Corporation had agreed to pay $2.49 billion for a controlling interest in a unit of Florida Cancer Specialists & Research Institute (FCS),¹ the news was jolting but not unexpected. There had been reports² and speculation for more than a year on who would be the winning suitor for FCS, with its 100 sites and a huge footprint in both the Florida market and the research community.